Found 126 matching trials
Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) PHASE2 This study is designed to evaluate the safety and immunogenicity of new for...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV PHASE3 The present clinical study will assess the immunogenicity and reactogenicit...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants. PHASE3 The purpose of this study is to evaluate the safety, reactogenicity and imm...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines PHASE3 The aims of this trial are to demonstrate the consistency of three manufact...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants PHASE3 The purpose of this study is to evaluate the safety and immunogenicity of t...
Show More Location
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Learn More & Join Trial
Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule PHASE3 Assess immuno, reacto of the 10-valent pneumococcal vaccine after 2 doses (...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age). PHASE3 This study will evaluate the immunogenicity of the co-administration of dif...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of Age NA Primary Objective:
To describe the persistence of Hep B antibodies (Ab) at...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine PHASE3 This study evaluates the immunogenicity and safety of Infanrix hexa™ (DTPa-...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule PHASE2 This is a booster study in 2 groups of healthy children less than 3 years o...
Show More Location
GSK Investigational Site
Learn More & Join Trial